HNGE HNGE Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value at other companies

Globus MedicalGMED

——

Other financials

Income statement

See full

Revenue$182.3M+47.2%

Gross profit$154.2M+53.9%

Operating income$32.1M+144%

Net income$35.1M+105%

EPS (diluted)$0.41-68.7%

Balance sheet

See full

Cash & equivalents$188.1M-35.2%

Total debt$7.0M—

Total equity$111.7M+136%

Total assets$728.8M—

Cash flow

See full

Operating cash flow$43.1M+775%

CapEx$83.0K+62.7%

Free cash flow$43.0M+782%

Valuation

See full

Market cap$5.37B—

Enterprise value$5.19B—

P/S8.3×—

Profitability

See full

Gross margin80.8%+1.5pp

Operating margin-85.8%—

Net margin-83.9%—

FCF margin32.3%—

Returns & leverage

See full

Return on equity551.8%—

Debt / equity0.1×—

Current ratio1.3×—

Where this comes from

Reported directly by HNGE in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue.

The official record: HNGE’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about HNGE's share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, aggregate intrinsic value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is HNGE's share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, aggregate intrinsic value?: HNGE (HNGE) reported share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, aggregate intrinsic value of $40M in Q1 2026.